strated a left ventricular ejection fraction of 10-15% and apical thrombus. Bilateral upper extremity Doppler showed deep venous thrombus in the left arm and superficial vein thrombus in both arms. She had reduced activity of antithrombin III, deficiency of protein C and S. Computed tomography of the head showed right thalamic infarct. Having failed optimal medical therapy, rapidly worsening of symptoms (New York Heart Association Class IV and clinical Class C) and cardiogenic shock, she underwent HeartWare V R left ventricular assist device (LVAD) placement as a bridge to heart transplant. Intraoperative apical thrombus was carefully extracted while maintaining adequate anticoagulation with heparin infusion. Pathology report of the excised apical myocardium and thrombus demonstrated haematopoietic cells. Twenty-six months since LVAD implantation, she remains active and Status 7 on transplant list (due to body mass index) without any further episodes of thromboembolic events. 
.. Discussion
We report an unprecedented case of an active young female with EMH within left ventricular myocardium and apical thrombus. Although redirected differentiation and embolic haematopoietic cells seem to explain this phenomenon, the exact pathophysiology remains unknown. Despite having pre-existing apical thrombus and acute deep vein thrombus, the key towards success was meticulous extraction of apical thrombus while preserving inherent trabecular architecture and adequate anticoagulation. 
Introduction
Extramedullary haematopoiesis (EMH) in the myocardium is a very rare finding, and its incidence in young adults remains unknown. In a small group of surgical cases, its incidence in adult (> _18 years) females were reported to be $1.4%. However, these patients had age >45 years and ischaemic heart disease. 1 Extramedullary haematopoiesis within left ventricle myocardium and apical thrombus in a young adult female had never been reported up until now; herein, we present a similar case with acutely decompensated heart failure and prothrombotic state, requiring left ventricular assist device (LVAD) implantation as a bridge to heart transplant (BTT).
Timeline Case presentation
A 23-year-old Caucasian female with past medical history of papillary thyroid cancer status post-complete thyroidectomy in total remission, iron deficiency anaemia, and Class 2 obesity [body mass index (BMI) 38.7 kg/m 2 ] presented to an out of network hospital with 1 day history of abdominal pain and diarrhoea, worsening dyspnoea on exertion, bilateral lower extremity oedema, paroxysmal nocturnal dyspnoea, and orthopnoea. A transthoracic echocardiogram (TTE) was notable for left ventricular ejection fraction (LVEF) of 10-15%, she was treated with diuretics and later discharged on guideline-directed medical therapy. Her symptoms progressively got worse for which she was transferred to the University of Pittsburgh Medical Center to be managed by the heart failure team. Computed tomography (CT) of head showed right thalamic infarct.
6 July 2016 A CT-guided bone marrow biopsy which showed trilineage haematopoiesis, mild erythroid hyperplasia, and polytypic plasmacytosis. Markedly depleted iron stores. Normal cytogenetic analysis. 8 July 2016
Started bridging to warfarin with a goal international normalized ratio of 2.0-3.0 17 October 2016 LVAD driveline infection with methicillin-susceptible Staphylococcus aureus.
November 2018
Patient remains active and stable on LVAD with Status 7 (due to body mass index) on heart transplant list.
Learning points
• An unprecedented case report of extramedullary haematopoiesis in the left ventricle myocardium and apical thrombus of a young adult female.
• Left ventricular assist device can be successfully implanted and maintained in a patient with acute heart failure with pre-existing apical thrombus, prothrombotic state, acute deep vein thrombus, and right thalamic infarct.
• Warfarin can be safely used for anticoagulation (goal international normalized ratio 2.0-3.0) in such patients with multiple comorbidities, with successful prevention of thromboembolic events and pump thrombus.
. 
She deteriorated rapidly exhibiting hypotension (89/44 mmHg), increased lactate level of 3.4 mMol/L (0.5-1.6), symptoms corresponding to New York Heart Association function Class IV while on 4 L of oxygen. Milrinone infusion (0.375 lg/kg/min) was started, and the decision was made to proceed with HeartWare V R LVAD (HeartWare, Inc., FL, USA) implantation as a BTT. Intraoperative transoesophageal echocardiogram again demonstrated an apical thrombus ( Figure 1A and B) . A circular ventriculotomy at the apex was performed, and the thrombus was extracted while taking care to preserve inherent trabecular architecture (Figure 2A and B) . Pathological analysis of the excised apical myocardium demonstrated endomyocardial fibrosis, EMH cells which stained positive for erythroid and myeloid series, and also haematopoietic cells were noted in the apical thrombus ( Figure 3A-D) . In the post-operative period, due to a persistent altered level of consciousness a computed tomography (CT) of the brain was done which showed the presence of right thalamic infarct. In retrospect, the patient reported an episode of left arm weakness which had resolved 1 week before current hospitalization. A CT-guided bone marrow biopsy from the right iliac crest showed normal trilineage haematopoiesis and markedly reduced iron staining. Flowcytometry and cytogenetic studies were normal. She was transitioned to oral warfarin for long-term anticoagulation [goal international normalized ratio (INR) 2.0-3.0] and discharged in stable condition.
Three months post-implant, she developed a driveline exit site infection for which she received vancomycin and underwent incision and drainage, during which an 8 cm pocket of infected haematoma was noted. Wound cultures grew Methicillin-susceptible Staphylococcus aureus (MSSA); accordingly, her antibiotic regimen was tailored. Due to multiple readmissions with driveline exit site infection and bacteraemia from MSSA, she was placed on cefadroxil for long-term antibiotic prophylaxis. Twenty-six months since LVAD implantation, she remains fairly active and Status 7 (due to BMI) on the transplant list without further thrombotic events.
Discussion
We report an unprecedented case of a young female with EMH within left ventricle myocardium and apical thrombus in acute heart failure. Extramedullary haematopoiesis in the heart is noticed during foetal life, but this gradually disappears soon when bone marrow becomes the primary site of haematopoiesis. There have been reports of EMH in non-hepatosplenic organs such as paravertebral column (mostly in the thorax), lymph nodes, retroperitoneum, lung, and pleura. 2 They often coexist with myelofibrosis, solid tumours, and other non-neoplastic disorders like thalassaemia. Multiple theories have been set forth to explain EMH, most common among them are, neoplastic, compensatory, and myelostimulatory. 3, 4 However, since our patient had no hepatosplenomegaly or retroperitoneal lymphadenopathy on CT scan of the abdomen and pelvis, in addition to unremarkable bone marrow biopsy, none of these theories seem to explain EMH. Most plausible explanation could be 'redirected differentiation theory' proposed by Koch et al. 2 Secretion of stimulatory factor in response to patient's severe iron deficiency anaemia and acute stress from decompensated heart failure could have stimulated differentiation of adult stem cell in the myocardium into haematopoietic lineage, while presence of haematopoietic cells in the apical thrombus could be explained by entrapment of haematopoietic precursor cells spilled into the blood stream during an accelerated bone marrow differentiation. Our case was unique and challenging in multiple ways. First, rapid decompensation without an immediate identifiable cause for nonischaemic cardiomyopathy. Second, preserving trabecular architecture during surgery to extract the LV thrombus whilst keeping the patient anticoagulated with a co-existing stroke. Finally, our patient had three relative contraindications (prothrombotic state, preexisting LV thrombus and obesity) for LVAD implantation. However, after discussion with the multidisciplinary team and in light of published literature 5 it was felt unfair to deny advance therapies, given her age and baseline functional status. Low antithrombin III, Protein C and S could be due to congenital deficiency, and/or acute thrombosis. Although there could have been a false positive effect due to active thrombosis, we could not repeat the test as this would require her anticoagulation to held, and given LVAD in situ this was deferred in patients best interest. Our experience aids the medical community in shared decision making during a similar challenge if faced during their clinical practice.
Conclusion
Extramedullary haematopoiesis in the LV myocardium and apical thrombus can be seen in active young females, pathophysiology of this phenomena needs further investigation. Left ventricular assist device can be successfully implanted and maintained in an acute heart failure patient with pre-existing LV thrombus, prothrombotic state, and cerebral infraction; while utilizing warfarin (goal INR 2.0-3.0) for therapeutic anticoagulation. EMH within left ventricle myocardium and apical thrombus in acute heart failure
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